Malin Corporation PLC Notice of 2022 Interim Results (1253X)
25 Agosto 2022 - 8:00AM
UK Regulatory
TIDM0Y71
RNS Number : 1253X
Malin Corporation PLC
25 August 2022
Malin Corporation plc
Notice of 2022 Interim Results
Dublin-Ireland, 25 August 2022 : Malin Corporation plc.
(Euronext Growth Dublin:MLC) ("Malin" or "the Company"), a company
investing in highly innovative life sciences companies, intends to
announce its interim financial results and publish its interim
report for the six month period ended 30 June 2022 at 07:00am Irish
Standard Time / BST on Wednesday, 7 September 2022.
Darragh Lyons, Chief Executive Officer, will host a conference
call at 12:00pm Irish Standard Time / BST on the day of
publication. This call can be accessed as follows:
From Ireland dial: 01 53695 84
From the UK dial: 020 3936 2999
From the USA dial: 1 646 664 1960
From all other locations dial: +44 203 936 2999
Participant access code: 978118
The Company's results press release and presentation will be
available on the Company's website from 07:00am Irish Standard Time
/ BST on 7 September 2022 at www.malinplc.com .
ENDS
About Malin Corporation plc
Malin (Euronext Growth Dublin:MLC) is a company investing in
highly innovative life sciences companies. Its purpose is to create
shareholder value through the application of long-term capital and
operational and strategic expertise to a diverse range of global
healthcare businesses. Malin has a focus on innovative businesses
underpinned by exceptional science and works with its investee
companies, providing strategic and financial support to enable them
to reach their value potential. Malin is headquartered and
domiciled in Ireland and listed on the Euronext Growth Dublin. For
more information visit www.malinplc.com
For further information contact:
ENDS
About Malin Corporation plc
Malin (Euronext Growth Dublin:MLC) is a company investing in
highly innovative life sciences companies. Its purpose is to create
shareholder value through the application of long-term capital and
operational and strategic expertise to a diverse range of global
healthcare businesses. Malin has a focus on innovative businesses
underpinned by exceptional science and works with its investee
companies, providing strategic and financial support to enable them
to reach their value potential. Malin is headquartered and
domiciled in Ireland and listed on the Euronext Growth Dublin. For
more information visit www.malinplc.com
For further information please contact:
Malin
Fiona Dunlevy, Company Secretary
Tel: +353 (0)1 901 5700
investorrelations@malinplc.com
Davy Corporate Finance (Euronext Growth Listing Sponsor &
Joint Broker)
Brian Garrahy / Daragh O'Reilly
Tel: +353 1 679 6363
Liberum (Joint Broker)
Phil Walker / Ben Cryer
Tel: +44 (0) 20 3100 2000
Powerscourt (Media enquiries)
Eavan Gannon
Tel: +353 87 236 5973
malin@powerscourt-group.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORFLFFETRISFIF
(END) Dow Jones Newswires
August 25, 2022 02:00 ET (06:00 GMT)
Grafico Azioni Malin (LSE:0Y71)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Malin (LSE:0Y71)
Storico
Da Mag 2023 a Mag 2024
